Technical Analysis for PFNX - Pfenex Inc.

Grade Last Price % Change Price Change
grade A 6.85 0.29% 0.02
PFNX closed up 0.29 percent on Friday, August 16, 2019, on 26 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical PFNX trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.29%
NR7-2 Range Contraction 0.29%
Upper Bollinger Band Walk Strength 0.29%
Upper Bollinger Band Touch Strength 0.29%
180 Bullish Setup Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Walk Strength 0.59%

Older signals for PFNX ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Pfenex Inc., a clinical-stage biotechnology company, is engaged in the development of biosimilar therapeutics. Its lead product candidate includes PF582, a biosimilar candidate to Lucentis that is in Phase Ib/IIa trials in patients with wet age-related macular degeneration. The company also develops PF530, an interferon beta-1b biosimilar candidate to the Betaseron to reduce the relapses in patients with relapsing forms of multiple sclerosis; PF694, an interferon alpha-2a biosimilar candidate to the reference product Pegasys; and other biosimilar candidates. In addition, it develops PF708, a teriparatide generic peptide product candidate to the reference listed drug Forteo; Px563L, an anthrax vaccine candidate based on a recombinant modified form of the protective antigen; and Px533, a prophylactic vaccine candidate to protect against malaria infection. The company has collaboration with Strides Arcolab Limited for the development of PF530. Pfenex Inc. is headquartered in San Diego, California.
Medicine Biotechnology Life Sciences Biology Drugs Multiple Sclerosis Wet Age Related Macular Degeneration Biosimilar Anthrax Antivirals Interferon
Is PFNX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 7.64
52 Week Low 3.13
Average Volume 158,857
200-Day Moving Average 5.304
50-Day Moving Average 6.4582
20-Day Moving Average 6.2505
10-Day Moving Average 6.482
Average True Range 0.4415
ADX 15.57
+DI 26.6544
-DI 17.7216
Chandelier Exit (Long, 3 ATRs ) 5.9355
Chandelier Exit (Short, 3 ATRs ) 6.9245
Upper Bollinger Band 7.117
Lower Bollinger Band 5.384
Percent B (%b) 0.85
BandWidth 27.725782
MACD Line 0.1376
MACD Signal Line 0.0237
MACD Histogram 0.1139
Fundamentals Value
Market Cap 161.16 Million
Num Shares 23.5 Million
EPS 0.06
Price-to-Earnings (P/E) Ratio 114.17
Price-to-Sales 1.08
Price-to-Book 1.09
PEG Ratio -0.03
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.30
Resistance 3 (R3) 7.32 7.19 7.23
Resistance 2 (R2) 7.19 7.08 7.18 7.20
Resistance 1 (R1) 7.02 7.00 6.96 7.00 7.17
Pivot Point 6.89 6.89 6.86 6.88 6.89
Support 1 (S1) 6.72 6.78 6.66 6.70 6.53
Support 2 (S2) 6.59 6.70 6.58 6.50
Support 3 (S3) 6.42 6.59 6.48
Support 4 (S4) 6.40